Nabil Hafez is an accomplished executive with extensive experience in sales, product management, and strategy within the healthcare and biotechnology sectors. Currently serving as Vice President of Sales at GenomOncology since April 2024, Nabil previously held the same title at PierianDx, overseeing sales and customer management for a SaaS product in NGS cancer diagnostics. Nabil's career includes significant roles at Sunquest Information Systems, Quest Diagnostics, GenomeQuest Inc., SeqWise LLC, and the Broad Institute of MIT/Harvard, where expertise was developed in product development, commercialization, and market strategy. Nabil holds an MBA in Marketing and Corporate Strategy from Duke University, an MS in Bioinformatics from Brandeis University, and a BS in Biology and Computer Science from Binghamton University.